Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early liver rejection

Am J Transplant. 2005 Jan;5(1):96-102. doi: 10.1111/j.1600-6143.2004.00639.x.

Abstract

To determine whether early acute cellular rejection (ACR) is associated with sub-optimal immunosuppression in children with liver transplants (LTx).

Methods: Twenty-five children with primary LTx after pre-transplant rabbit anti-thymocyte globulin (rATG), and steroid-free tacrolimus (TAC) were evaluated. Mitogen-stimulated T- and B-cell responses and mixed lymphocyte response to donor and third-party antigens were performed at several time points between two consecutive TAC doses. TAC concentrations (C) associated with half-maximal effect (EC(50)) on lymphocytes was determined by pharmacodynamic equations.

Results: Mean age was 7.2 +/- 6.2 years, mean time to lymphocyte function studies was 25 +/- 19 days. Acute rejection occurred at a mean interval of 31 +/- 19 days after LTx. Rejectors (n = 16) demonstrated significantly higher EC(50) of TAC for the intra-cellular IFN-gamma in T cells (p = 0.005) and its CD8+ sub-population (p = 0.027) as well as the co-stimulatory/activation receptor CD54 on B cells (p = 0.0001). The response of recipient lymphocytes to donor antigen was significantly higher in rejectors, compared with non-rejectors (p = 0.015). The patient groups demonstrated no differences in third-party MLR, or in C of TAC.

Conclusions: Independent of the amount of immunosuppressant, ACR of liver allografts in children is associated with enhanced donor-specific alloreactivity. This is accompanied by a cytotoxic T-cell sub-population with increased requirement for TAC.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Animals
  • Antigens / chemistry
  • Antigens, CD19 / biosynthesis
  • CD8-Positive T-Lymphocytes / immunology
  • Child
  • Child, Preschool
  • Female
  • Flow Cytometry
  • Graft Rejection
  • Humans
  • Immune Tolerance
  • Immunosuppression Therapy
  • Immunosuppressive Agents / pharmacology*
  • Infant
  • Interferon-gamma / metabolism
  • Liver / immunology
  • Liver Transplantation / methods*
  • Lymphocyte Subsets
  • Lymphocytes / immunology
  • Male
  • Rabbits
  • Spleen / cytology
  • Steroids / metabolism
  • T-Lymphocytes / immunology
  • Tacrolimus / metabolism
  • Time Factors
  • Tissue Donors

Substances

  • Antigens
  • Antigens, CD19
  • Immunosuppressive Agents
  • Steroids
  • Interferon-gamma
  • Tacrolimus